Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Fu, Maoyong; Maresh, Erin L; Soslow, Robert A; Alavi, Mohammad; Mah, Vei; Zhou, Qin; Iasonos, Alexia; Goodglick, Lee; Gordon, Lynn K; Braun, Jonathan; Wadehra, Madhuri

Fu, Maoyong; Maresh, Erin L; Soslow, Robert A; Alavi, Mohammad; Mah, Vei; Zhou, Qin; Iasonos, Alexia; Goodglick, Lee; Gordon, Lynn K; Braun, Jonathan; Wadehra, Madhuri.

Affiliation

Fu M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Clin Cancer Res ; 16(15): 3954-63, 2010 Aug 01.

Article in En | MEDLINE | ID: mdl-20670949

Subject(s)

Membrane Glycoproteins/biosynthesis; Ovarian Neoplasms/metabolism; Adult; Aged; Animals; Antineoplastic Agents/pharmacology; Blotting, Western; Female; Gene Expression; Gene Expression Profiling; Humans; Immunoglobulin Fragments/pharmacology; Immunohistochemistry; Immunotherapy/methods; Membrane Glycoproteins/antagonists & inhibitors; Mice; Mice, Nude; Middle Aged; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/pathology; Tissue Array Analysis; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Membrane Glycoproteins Type of study: Prognostic_studies Limits: Adult / Aged / Animals / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google